RecruitingNCT06092346
Rare condition
X-linked Charcot-Marie-Tooth disease type 1
4
studies recruiting now
as of 7 Sept 2026
8
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
10 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07461896
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
RecruitingNCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RecruitingNot applicableNCT05982119
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all X-linked Charcot-Marie-Tooth disease type 1 studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new X-linked Charcot-Marie-Tooth disease type 1 study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About X-linked Charcot-Marie-Tooth disease type 1
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (GJB1).
Treatments being studied
8 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Sorbitol (Sorbitol component of -mannitol)
Phase 3Baclofen (Baclofen)
Phase 3Naltrexone Hydrochloride (Adepend)
Phase 2Efmitermant Alfa
Phase 2Epalrestat
Phase 2Mexiletine
Phase 1/2Ubidecarenone
Phase 1/2Donaperminogene Seltoplasmid
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).